www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

AstraZeneca to build $200m center in China

Updated: 2011-10-12 09:56

By Ma Zhenhuan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

AstraZeneca to build $200m center in China

AstraZeneca PLC workers load blister strips onto a packing line at a factory in Macclesfield, United Kingdom. The UK-based medical company will create 600 jobs by building a new factory in Taizhou, Jiangsu province. [Photo / Bloomberg]

SHANGHAI - AstraZeneca PLC, one of the world's leading pharmaceutical companies, said it would invest $200 million to launch a new manufacturing facility in China to meet growing demand, including in rural areas.

Construction work on the project, in the China Medical City in Taizhou of East China's Jiangsu province, is scheduled for completion by the end of 2013, creating approximately 600 jobs.

This will be London-based AstraZeneca's largest single investment in a manufacturing facility globally. The new plant will produce intravenous and oral solid products, the company said.

"The new facility will significantly enhance our capacity and allow us to meet the growing healthcare demand of the Chinese population, and help us expand into the 900 million (rural) people outside of the big cities and hospitals," Mark Mallon, president of AstraZeneca China, told China Daily in an exclusive interview on Monday.

"It will also allow us to free up some capacity at our existing manufacturing facility in Wuxi, Jiangsu, to bring on more new innovative products that will be launched over the next few years," he added.

The Chinese pharmaceutical market grew from $10 billion in 2004 to $41 billion in 2010, according to market research agency IMS Health Inc, and it is expected to reach $102 billion by 2015.

Mallon said that he believes the Chinese government's focus on healthcare reform and investment in improving healthcare infrastructure and expanding insurance coverage will continue to drive the company's business growth and increase access to quality medicines over the longer term.

AstraZeneca will launch two new products, Faslodex, a treatment for breast cancer, and Onglyza, a new treatment for Type-2 Diabetes, in China this year.

Mallon also mentioned that the company is planning to launch Brilinta, an oral antiplatelet treatment for acute coronary syndrome, next year in China.

With an enhanced manufacturing capacity and the launch of more innovative new medicines, the company is planning to produce more affordable medicines for Chinese patients. It will adopt a multi-channel approach to sell its products to markets beyond big cities and hospitals.

Aside from the medical sales representatives who deal with individual physicians in big cities, the company has developed a team of about 100 customer service representatives who organize educational programs for small clinics and community health centers in China's rural areas.

It will also set up an inbound and outbound call center to reach out to healthcare professionals through phone calls, helping them learn more about AstraZeneca products, he said.

The company, which entered China in 1993, has invested about $500 million in the country, including an innovation center in Zhangjiang, Shanghai.

主站蜘蛛池模板: 国产激情视频在线 | 偷柏自拍亚洲欧美综合在线图 | 成年人看的黄色片 | 久久久久依人综合影院 | 国产在线精品观看 | 女人扒开双腿让男人捅 | 手机看片av| 国产在线观看高清精品 | 亚洲精品视频免费观看 | 亚洲男人的天堂网 | 久久三级国产 | 国产无套视频在线观看香蕉 | 亚洲国产精品乱码在线观看97 | 欧美一级俄罗斯黄毛片 | 泰国情欲片寂寞的寡妇在线观看 | 一级 黄 色 片免费 一级aaaaaa毛片免费 | 大量愉拍情侣在线视频 | 欧美一级片免费在线观看 | 午夜寂寞福利 | 精品成人免费视频 | 色伦网 | 丁香五香天堂 | 日韩欧免费一区二区三区 | 日韩三级一区二区 | 亚欧人成精品免费观看 | 亚洲成在人线久久综合 | 91精品久久 | 国产美女在线一区二区三区 | 久久久久久久久中文字幕 | 欧美亚洲综合网 | 成人午夜在线观看国产 | 黄色大秀视频 | 亚洲一区二区三区在线播放 | 国产步兵社区视频在线观看 | 成年人免费观看的视频 | 亚洲成在线观看 | 亚洲国产精品久久久天堂 | 国产视频自拍偷拍 | 韩国精品视频在线观看 | 天堂男人在线 | 亚洲乱淫|